A multi-centre, randomised, double blind, placebo-controlled trial evaluating the effects of early administration of fibrinogen concentrate in adults with major traumatic haemorrhage. E-FIT 1 Study
Phase of Trial: Phase II
Latest Information Update: 03 May 2017
At a glance
- Drugs Fibrinogen (Primary)
- Indications Haemorrhage
- Focus Therapeutic Use
- Acronyms E-FIT 1
- 01 May 2017 Status changed from active, no longer recruiting to completed.
- 11 Feb 2016 Status changed from not yet recruiting to recruiting as reported by United Kingdom Clinical Research Network record.
- 11 Aug 2015 Status changed from recruiting to active, no longer recruiting.